Cardiopulmonary and arterial baroreceptor unloading during passive hyperthermia does not contribute to hyperthermia-induced hyperventilation

New Findings What is the central question of this study? Does baroreceptor unloading during passive hyperthermia contribute to increases in ventilation and decreases in end-tidal carbon dioxide during that exposure? What is the main finding and its importance? Hyperthermic hyperventilation is not mitigated by expanding central blood volume and reloading the cardiopulmonary baroreceptors via rapid saline infusion or by reloading the arterial baroreceptors via phenylephrine administration. The absence of a reduction in ventilation upon reloading the baroreceptors to pre-hyperthermic levels indicates that cardiopulmonary and arterial baroreceptor unloading with hyperthermia is unlikely to contribute to hyperthermic hyperventilation in humans. This study tested the hypothesis that baroreceptor unloading during passive hyperthermia contributes to increases in ventilation and decreases in end-tidal partial pressure of carbon dioxide (P ET ,CO2) during that exposure. Two protocols were performed, in which healthy subjects underwent passive hyperthermia (increasing intestinal temperature by approximate to 1.8 degrees C) to cause a sustained increase in ventilation and reduction in P ET ,CO2. Upon attaining hyperthermic hyperventilation, in protocol1 (n=10; three females) a bolus (19 +/- 2mlkg(-1)) of warm (approximate to 38 degrees C) isotonic saline was rapidly (5-10min) infused intravenously to restore reductions in central venous pressure, whereas in protocol2 (n=11; five females) phenylephrine was infused intravenously (60-120gmin(-1)) to return mean arterial pressure to normothermic levels. In protocol1, hyperthermia increased ventilation (by 2.2 +/- 1.7lmin(-1), P<0.01), while reducing P ET ,CO2 (by 4 +/- 3mmHg, P = 0.04) and central venous pressure (by 5 +/- 1mmHg, P <0.01). Saline infusion increased central venous pressure by 5 +/- 1 mmHg (P<0.01), restoring it to normothermic values, but did not change ventilation or P ET ,CO2 (P>0.05). In protocol2, hyperthermia increased ventilation (by 5.0 +/- 2.7lmin(-1), P <0.01) and reduced P ET ,CO2 (by 5 +/- 2 mmHg, P<0.01) and mean arterial pressure (by 9 +/- 7mmHg, P <0.01). Phenylephrine infusion increased mean arterial pressure by 12 +/- 3mmHg (P<0.01), restoring it to normothermic values, but did not change ventilation or P ET ,CO2 (P>0.05). The absence of a reduction in ventilation upon reloading the cardiopulmonary and arterial baroreceptors to pre-hyperthermic levels indicates that baroreceptor unloading with hyperthermia is unlikely to contribute to hyperthermic hyperventilation in humans.